Details for 2017859227
Up to date per 03.04.2026
Actions
Details for 2017859227
Deleted
European Patent
14.08.2019 A
07.06.2023 B1
05.10.2016
US
201662404643 P
A61K 9/00 20060101AFI20221111BHEP
Owner
TITAN PHARMACEUTICALS, INC.400 Oyster Point Blvd., Suite 505 South San Francisco, CA 94080-1958US
Representative
No representatives present
Inventor
PATEL, Rajesh A.c/o Titan Pharmaceuticals, Inc. 400 Oyster Point. Blvd. Suite 505 South San Francisco, CA 94080-1958US
SREEDHARAN, Sunilc/o Titan Pharmaceuticals, Inc. 400 Oyster Point. Blvd. Suite 505 South San Francisco, CA 94080-1958US
BHONSLE, Sunil R.c/o Titan Pharmaceuticals, Inc. 400 Oyster Point. Blvd. Suite 505 South San Francisco, CA 94080-1958US